The expression of FMR4, FMR5, and FMR6 is detectable in the majority of patient leukocyte RNA samples, suggesting that it may be reliable biomarkers for FXS (Wahlestedt, 2013). The gene discussed is FMR1-AS1; the disease is fragile X syndrome.